Prokocimer Philippe 4/A
4/A · Trius Therapeutics Inc · Filed May 28, 2013
Insider Transaction Report
Form 4/AAmended
Prokocimer Philippe
Chief Medical Officer
Transactions
- Sale
Common Stock
2013-05-13$7.65/sh−12,000$91,800→ 98,022 total(indirect: By Trust)
Holdings
- 10,429
Common Stock
Footnotes (2)
- [F1]The reporting person filed a Form 4 reporting a sale of 12,000 shares of common stock on May 13, 2013 which was cancelled by the broker. As of May 13, 2013, the reporting person owned 98,022 shares of common stock indirectly by trust.
- [F2]Includes 396 and 534 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on 5/18/12 and 11/20/12, respectively.